Evidence from crossover trials: Empirical evaluation and comparison against parallel arm trials

International Journal of Epidemiology

Volumn 36, Issue 2, 2007, Pages 422-430

  Lathyris, Dimitrios N ^a   Trikalinos, Thomas A ^a,b   Ioannidis, John P A ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crossover studies; Empirical evaluation; Meta analysis; Parallel studies

Indexed keywords

EMPIRICAL ANALYSIS; ESTIMATION METHOD; HEALTH CARE; META-ANALYSIS;

CLINICAL STUDY; COCHRANE LIBRARY; DATA EXTRACTION; METHODOLOGY; PARALLEL DESIGN; PRIORITY JOURNAL; QUANTITATIVE STUDY; RANDOMIZATION; REVIEW; RISK; STATISTICAL ANALYSIS;

CROSS-OVER STUDIES; EVALUATION STUDIES; FEMALE; HUMANS; MALE; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS;

EID: 34447311367     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dym001     Document Type: Review

References (49)

1. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G and Altman DG (eds). Systematic Reviews in Health Care. Meta-Analysis in Context. 2nd edn., London: BMJ Books, 2001.
2. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: Methodological issues. Int J Epidemiol 2002;31:140-49.
3. Garcia R, Benet M, Arnau C, Cobo E. Efficiency of the crossover design: an empirical estimation. Stat Med 2004;23:3773-80.
4. John JA, Russell KG, Whitaker D. Crossover: An algorithm for the construction of efficient crossover designs. Stat Med 2004;23 2645-58.
5. Senn S. Misunderstandings regarding clinical crossover trials. Stat Med 2005;24:3675-78.
6. Cochrane Collaboration. Reviewers' Handbook 8.11.3.
7. Rosenthal R. Parametric measures of effect size. In: Cooper H and Hedges LV (eds). The Handbook of Research Synthesis. New York: Russell Sage Foundation, 1994.
8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986;7:177-88.
9. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for Meta-Analysis in Medical Research. London: Wiley, 2004.
10. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
11. Ioannidis JPA, Cappeleri JC, Lau J. Issues in comparisons of meta-analyses and large trials. JAMA 1998;279:1089-93.
12. Sterne JA, Juni P, Schulz KF, Altman DG, Bartlett C, Egger M. Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research. Stat Med 2002;21:1513-24.
13. Hasselblad V, Hedges LV. Meta-analysis of screening and diagnostic tests. Psychol Bull 1995;117:167-78.
14. Fleiss JL. Analysis of data from multiclinic trials. Controlled Clin Trials 1986;7:267-75.
15. Gotzsche PC, Johansen HK. Short-term low dose corticosteroids vs placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
16. Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P. Methotrexate for treating rheumatoid arthritis (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
17. Ferreira IM, Brooks D, Lacasse Y, Goldstein RS, White J. Nutritional supplementation for stable chronic obstructive pulmonary disease (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
18. Pinelli J, Symington A. Non nutritive sucking for promoting physiologic stability and nutrition in preterm infants (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
19. White J, Cates C, Wright J. Continuous positive airways pressure for obstructive sleep apnoea (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
20. Poustie VJ, Rutherford P. Dietary interventions for phenylketonuria (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
21. Suarez-Almazor ME, Spooner C, Belseck E. Azathioprine for treating rheumatoid arthritis (Cochrane review). The Cochrane Librar. Issue 2. Oxford: Update Software, 2003.
22. Brion LP, Primhak RA, Ambrosio-Perez I. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
23. Lemyre B, Davis PG, De Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
24. Lonergan E, Luxenberg J, Colford J. Haloperidol for agitation in dementia (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
25. Jones A. Fay JK, Burr M, Stone M, Hood Y, Roberts G. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease (Cochrane review). The Cochrane Library Issue 2. Oxford: Update Software, 2003.
26. Green S, Buchbinder R, Barnsley L, Hall S, White M, Smidt N, Assenbelft W. Non-steroidal anti-inflammatory drugs (NSAIDS) for treating lateral elbow pain in adults (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
27. Riemsma RP, Kirwan JR, Taal E, Rasker JJ. Patient education for adults with rheumatoid arthritis (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
28. McCrory DC, Brown CD. Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease (Cochrane review). The Cochrane Library Issue 2. Oxford: Update Software, 2003.
29. Jurgens G, Graudal NA. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols and triglyceride (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
30. Toweed TE, Judd MJ, Hochberg MC, Wells G. Acetaminophen for osteoarthritis (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
31. Hughes E, Collins J, Vandekerckhove P. Clomiphene citrate for unexplained subfertility in women (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
32. Cheine M, Ahonen J, Wahlbeck K. Beta-blocker supplementation of standard drug treatment for schizophrenia (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
33. Clarke CE, Speller JM. Pergolide versus bromocriptine for levodopa-induced complications in Parkinsons disease (Coharane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
34. Ortiz Z, Shea B, Suarez-Almazor ME, Moher D, Wells G, Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
35. Higgins JPT, Flicker L. Lecithin for dementia and cognitive impairment (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
36. Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
37. Melchart D, Linde K, Fischer P et al. Acupuncture for idiopathic headache (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
38. Sultana A, Reilly J, Fenton M. Thioridazine for schizophrenia (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
39. Proctor ML, Smith CA, Farquhar CM, Stones RW. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea (Cochrane review). The Cochrane Libraty. Issue 2. Oxford: Update Software, 2003.
40. Hood WBJr, Dans AL, Guyatt GH, Jaeschke R, McMurray JJV. Digitalis for treatment of congestive heart failure in patients in sinus rhythm (Cochrane review). The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
41. Karassa FB, Tatsioni A, Ioannidis JP. Design, quality, and bias in randomized controlled trials of systemic lupus erythematosus. J Rheumatol 2003;30:979-84.
42. Kyriakidi M, Ioannidis JPA. Design and quality considerations for randomized controlled trials in systemic sclerosis. Arthritis Rheum 2002;47:73-81.
43. Jadad AR, Moher M, Browman GP et al. Systematic reviews and meta-analyses on treatment of asthma: Critical evaluation. Br Med J 2000;320:537-40.
44. Van Coevorden AK Coenraads PJ, Svensson A et al. European Dermato-Epidemiology Network (Eden). Overview of studies of treatments for hand eczema-the EDEN hand eczema survey. Br J Dermatol 2004; 151:446-51.
45. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997;315 629-34.
46. Ioannidis JP, Cappelleri JC, Sacks HS, Lau J. The relationship between study design, results, and reporting of randomized clinical trials of HIV infection. Control Clin Trials 1997;18:431-44.
47. Sterne JA, Davey Smith G. Sifting the evidence-what's wrong with significance tests? Br Med J 2001;322:226-31.
48. Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124.
49. Senn S. The quality of systematic reviews. Review is biased. Br Med J 2000;321:297.